Team:UPO-Sevilla/Notebook/09 07

From 2010.igem.org

(Difference between revisions)
 
Line 27: Line 27:
       <h2>Assembly Team</h2>
       <h2>Assembly Team</h2>
-
       <p>We analyzed our work and determined the most important biobricks to be built. Most of them are still uncompleted, but time is running out. A new distribution of the sources was done this week. I began with the digestion of the unavailable biobricks and the purification of available ones. We lost 2+6 (not digested). After that, we proceeded to join the biobricks: (1+2)+(7+2), 4+3, 4+ pSB1C3 by ligation (o/n)</p>
+
       <p>We analyzed our work and determined the most important biobricks to be built. Most of them are still uncompleted, but time is running out. A new distribution of the sources was done this week. We began with the digestion of the unavailable biobricks and the purification of available ones. We lost 2+6 (not digested). After that, we proceeded to join the biobricks: (1+2)+(7+2), 4+3, 4+ pSB1C3 by ligation (o/n)</p>
       <h2>Assay Team</h2>
       <h2>Assay Team</h2>

Latest revision as of 15:08, 27 October 2010

September, 7th

Production Team

We performed the first overlapping PCR for SDM. We performed three reactions to be able of obtain fecI-fecR and fecR parts by mutagenesis. In each reaction the mix was:

37’5 ul H2O + 0,5ul UPO28* + 4 ul dNTP (10mM) + 5 ul Pfu buffer + 1 ul Pfu + 1 ul A-primer + 1 ul B-primer = 50 ul Vt

Next we performed a preparative electrophoresis with PCR’s products. 0,8% gel electrophoresis showed that we obtained amplification enough to mutagenize fecR, but not fecI-fecR composite part. We isolated from gel the amplified parts, products of the first PCR reaction needed to the next one.

Assembly Team

We analyzed our work and determined the most important biobricks to be built. Most of them are still uncompleted, but time is running out. A new distribution of the sources was done this week. We began with the digestion of the unavailable biobricks and the purification of available ones. We lost 2+6 (not digested). After that, we proceeded to join the biobricks: (1+2)+(7+2), 4+3, 4+ pSB1C3 by ligation (o/n)

Assay Team

We started with a chemotaxis assays series today. We studied some possible strategies we could follow in order to see chemotaxis in bacteria (quantitative and qualitative assays).

We designed the method to put into practice the capillary assay developed by Adler and we prepared the material to carry it out.

Go to 3rd of September Go to 8th of September
Return to Notebook

Footer